438 related articles for article (PubMed ID: 17446262)
21. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
22. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
23. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
Subramanian V; Doddapaneni H; Syed K; Yadav JS
Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
[TBL] [Abstract][Full Text] [Related]
24. Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activity.
Wei L; Locuson CW; Tracy TS
Mol Pharmacol; 2007 Nov; 72(5):1280-8. PubMed ID: 17686967
[TBL] [Abstract][Full Text] [Related]
25. The FMN "140s Loop" of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450.
Rwere F; Im S; Waskell L
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638963
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
27. Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors.
Crewe HK; Barter ZE; Yeo KR; Rostami-Hodjegan A
Biopharm Drug Dispos; 2011 Sep; 32(6):303-18. PubMed ID: 21725985
[TBL] [Abstract][Full Text] [Related]
28. The role of the length and sequence of the linker domain of cytochrome b5 in stimulating cytochrome P450 2B4 catalysis.
Clarke TA; Im SC; Bidwai A; Waskell L
J Biol Chem; 2004 Aug; 279(35):36809-18. PubMed ID: 15194706
[TBL] [Abstract][Full Text] [Related]
29. The high-level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function.
Holmans PL; Shet MS; Martin-Wixtrom CA; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1994 Aug; 312(2):554-65. PubMed ID: 8037471
[TBL] [Abstract][Full Text] [Related]
30. Heterologous expression of fungal cytochromes P450 (CYP5136A1 and CYP5136A3) from the white-rot basidiomycete Phanerochaete chrysosporium: Functionalization with cytochrome b5 in Escherichia coli.
Hatakeyama M; Kitaoka T; Ichinose H
Enzyme Microb Technol; 2016 Jul; 89():7-14. PubMed ID: 27233123
[TBL] [Abstract][Full Text] [Related]
31. Role of cytochrome b5 in catalysis by cytochrome P450 2B4.
Zhang H; Myshkin E; Waskell L
Biochem Biophys Res Commun; 2005 Dec; 338(1):499-506. PubMed ID: 16182240
[TBL] [Abstract][Full Text] [Related]
32. Enzyme source effects on CYP2C9 kinetics and inhibition.
Kumar V; Rock DA; Warren CJ; Tracy TS; Wahlstrom JL
Drug Metab Dispos; 2006 Nov; 34(11):1903-8. PubMed ID: 16928789
[TBL] [Abstract][Full Text] [Related]
33. The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5).
Im SC; Waskell L
Arch Biochem Biophys; 2011 Mar; 507(1):144-53. PubMed ID: 21055385
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional characterization of a cytochrome P450 2B4 F429H mutant with an axial thiolate-histidine hydrogen bond.
Yang Y; Zhang H; Usharani D; Bu W; Im S; Tarasev M; Rwere F; Pearl NM; Meagher J; Sun C; Stuckey J; Shaik S; Waskell L
Biochemistry; 2014 Aug; 53(31):5080-91. PubMed ID: 25029089
[TBL] [Abstract][Full Text] [Related]
36. Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process.
Schenkman JB; Voznesensky AI; Jansson I
Arch Biochem Biophys; 1994 Oct; 314(1):234-41. PubMed ID: 7944401
[TBL] [Abstract][Full Text] [Related]
37. Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions.
Guryev OL; Gilep AA; Usanov SA; Estabrook RW
Biochemistry; 2001 Apr; 40(16):5018-31. PubMed ID: 11305918
[TBL] [Abstract][Full Text] [Related]
38. Expression, purification, and physical properties of recombinant flavocytochrome fusion proteins containing rat cytochrome b(5) linked to NADPH-cytochrome P450 reductase by different membrane-binding segments.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Arch Biochem Biophys; 2001 Jun; 390(2):222-34. PubMed ID: 11396925
[TBL] [Abstract][Full Text] [Related]
39. Influence of fluorescent probe size and cytochrome b5 on drug-drug interactions in CYP2C9.
Hummel MA; Tracy TS; Hutzler JM; Wahlstrom JL; Zhou Y; Rock DA
J Biomol Screen; 2006 Apr; 11(3):303-9. PubMed ID: 16490777
[TBL] [Abstract][Full Text] [Related]
40. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
